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Abstract
The structure of retinol dehydratase (DHR) from Spodoptera frugiperda, a member of the sulfotransferase
superfamily, in complexes with the inactive form of the cofactor PAP 3-phosphoadenosine 5-phosphate
(PAP) and (1) the product of the reaction with retinol anhydroretinol (AR), (2) the retinoid inhibitor
all-trans-4-oxoretinol (OR), and (3) the potent steroid inhibitor androsterone (AND) have been determined
and compared to the enzyme complex with PAP and retinol. The structures show that the geometry of the
active-site amino acids is largely preserved in the various complexes. However, the -ionone rings of the
retinoids are oriented differently with respect to side chains that have been shown to be important for the
enzymatic reaction. In addition, the DHR:PAP:AND complex reveals a novel mode for steroid binding that
contrasts significantly with that for steroid binding in other sulfotransferases. The molecule is displaced and
rotated ∼180° along its length so that there is no acceptor hydroxyl in close proximity to the site of sulfate
transfer. This observation explains why steroids are potent inhibitors of retinol dehydratase activity, rather
than substrates for sulfonation. Most of the steroid-protein contacts are provided by the -helical cap that
distinguishes this member of the superfamily. This observation suggests that in addition to providing a
chemical environment that promotes the dehydration of a sulfonated intermediate, the cap may also serve
to minimize a promiscuous sulfotransferases activity.
Keywords: X-ray crystallography; retinol dehydratase; sulfotransferase; anhydroretinol
Cytosolic sulfotransferases (STs) catalyze the transfer of a
sulfate group from the universal sulfate donor 3-phos-
phoadenosine 5-phosphosulfate (PAPS) onto a hydroxyl or
amino group of a large number of structurally diverse ac-
ceptor molecules, such as steroids, hormones, neurotrans-
mitters, and other endogenous or xenobiotic compounds
(Weinshilboum et al. 1997; Strott 2002; Chapman et al.
2004). Sulfation of metabolites commonly leads to their
inactivation and elimination by increasing their water solu-
bility and decreasing biological activity (Falany 1997). Re-
cent data have also implicated STs in a number of disease
states, such as chronic inflammation (Kansas 1996), entry of
HIV (Farzan et al. 1999; Cormier et al. 2000), and various
forms of cancer (Falany 1997; Weinshilboum et al. 1997;
Armstrong and Bertozzi 2000). For example, STs have been
shown to produce highly reactive intermediates (e.g., N-
hydroxy heterocyclic and aromatic arylamines) that bind
DNA and promote mutations (Yamazoe et al. 1999). For
this reason, there is growing interest in the study of substrate
binding and inhibition mechanisms of STs.
Crystal structures of several STs have been reported
(Gamage et al. 2003, and references therein; Lee et al.
2003). Structural studies have shown that despite low to
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moderate sequence identity between ST subfamilies, the
overall molecular fold of all known STs is surprisingly simi-
lar. As one might infer by the diverse substrates recognized
by individual members of the superfamily, the acceptor sub-
strate binding pockets are the least conserved parts of the ST
molecules.
Retinol dehydratase (DHR) from Spodeptera frugiperda
is currently the only insect sulfotransferase for which a
structure has been determined. The enzyme catalyzes the
conversion of all-trans-retinol (RTL) to anhydroretinol
(AR) (Fig. 1), a retro-retinoid that appears to play a role in
morphogenesis. AR is also present in a number of mamma-
lian cell types including liver, kidney, and lung (Buck et al.
1993). However, mammalian enzymes responsible for the
production of AR have yet to be identified.
DHR has several unique features that distinguish it from
other members of the ST family. The enzyme has low-
sequence identity to the most homologous sulfotransferase
rat aryl sulfotransferase (30%) and is significantly larger (41
kDa) than mammalian STs (30–36 kDa). However, se-
quence-alignment analyses and kinetic studies invariantly
classify this enzyme as a member of the sulfotransferase
superfamily (Vakiani et al. 1998). As a typical cytosolic
sulfotransferase, DHR sulfonates a wide variety of different
hydroxycompounds, such as p-nitrophenol, phenol, vanillin,
and serotonin. Some steroids bind tightly to DHR, in par-
ticular hydrocortisone and androsterone. However, these
compounds do not appear to be substrates, as no sulfonated
products are detected under standard assay conditions (Va-
kiani et al. 1998). On the other hand, other sulfotransferases
do not seem to utilize retinol or other retinoids as substrates
(Vakiani et al. 1998). The feature that most distinguishes
DHR from other STs is that the end product of the enzy-
matic reaction, anhydroretinol, is not sulfonated. Retinyl
sulfate appears to be a transient intermediate in the trans-
formation of retinol to anhydroretinol.
We have previously shown (Pakhomova et al. 2001) that
the insertion of the 32-residue helical “lid” domain into the
canonical sulfotransferase fold is responsible for the func-
tional transformation of a sulfotransferase to a dehydratase.
We also showed that a DHR deletion mutant that lacks the
lid domain retains sulfotransferase activity, but no longer
functions as a dehydratase. On the basis of biochemical and
structural data, a mechanism for the enzymatic reaction was
proposed. However, structural information was limited to
the enzyme:PAP:substrate complex. In this article, we pre-
sent the results of three crystal structure determinations of
ternary complexes of the enzyme with (1) the potent steroid
inhibitor androsterone, (2) the product of the reaction an-
hydroretinol, and (3) the retinoid inhibitor (all-trans-4-oxo-
retinol) (Fig. 2), all in the presence of PAP. These structures
provide a more detailed picture of the enzymatic reaction
and help to explain differences between DHR and other
members of the ST super-family.
Results and Discussion
As previously described (Pakhomova et al. 2001), the over-
all molecular fold of DHR is an / motif with a central
Figure 1. Retinol dehydratase-catalyzed reaction.




five-stranded parallel -sheet surrounded by -helices (Fig.
3). The lid domain, the addition to the canonical sulfotrans-
ferase fold, closes the entrance to the enzyme’s active site.
The fully encapsulated active site is predominantly hydro-
phobic with a high proportion of aromatic residues (two phe
and four tyr) in addition to the highly conserved amino acids
that participate in sulfate transfer (R73, K162, H164, and
H197), which may serve to promote desulfonation of the
sulfonated intermediate. A comparison of the three crystal
structures determined here reveals that active-site geometry
is preserved in the various complexes, i.e., the binding of
ligands that differ in chemical structure (the steroid andros-
terone vs. retinol) leads to only limited structural differences
in the active site of the enzyme. The helical lid appears to
allow the enzyme to trap substrates and inhibitors in distinct
positions in the active site.
The DHR:androsterone complex
Steroids that serve as substrates for steroid sulfotransferases
are potent inhibitors of retinol dehydratase activity. Despite
the fact that steroids bind to the active site of DHR, the
enzyme does not sulfonate these compounds. To elucidate
the mechanism of inhibition of DHR by androsterone
(Ki = 0.11 M), we solved the structure of DHR in the
ternary complex with PAP and AND. The structure reveals
a novel mode for steroid binding that contrast significantly
with that for steroid binding in other sulfotransferases (Fig.
4). The steroid is displaced and rotated ∼180° along the
length of the molecule, so that there is no acceptor hydroxyl
in close proximity to the site of sulfate transfer, consistent
with the fact that steroids are not converted into sulfonated
products. Most of the steroid–protein contacts are provided
by the -helical cap that distinguishes this member of the
superfamily. This observation suggests that in addition to
providing a chemical environment that promotes the dehy-
dration of a sulfonated intermediate, the cap may also serve
to minimize a promiscuous sulfotransferase activity. STs, in
general, accommodate chemically diverse substrates in ac-
tive sites with unobstructed access. The lid may help to
restrict access to the catalytic machinery, and in this case,
holds a potential substrate just out of reach (Fig. 5A). Only
F130 is positioned differently (with respect to its orientation
in the DHR:PAP:RTL structure previously described) in the
inhibited complex—in the DHR:PAP:AND structure the ro-
tamer of F310 is that most commonly observed. This dif-
ference is likely a consequence of the fact that this end of
the binding site is not occupied by the steroid inhibitor, but
is occupied in the DHR:substrate structure by the isoprene
tail of the retinol.
Specific contacts that restrain AND include water-medi-
ated hydrogen bonds between the C3 hydroxyl and the car-
bonyl oxygen of Y120 and the hydroxyl of Y135 of the lid
domain. Additional stabilization of the complex is provided
by van der Waals contacts contributed by both residues
from the helical insert (I111, L139, L138) and the canonical
ST fold (F31, L201, Y298, M295). The lack of any direct
H-bond interactions between the protein and inhibitor, or
more extensive hydrophobic interactions, is somewhat sur-
prising, given the affinity of the inhibitor for the enzyme,
but not without precedent. The family of intracellular fatty
acid-binding proteins that includes proteins specific for fatty
acids and retinoids encapsulate their ligands in oversized
cavities with limited chemical complementarity to their re-
spective substrates (Newcomer et al. 1998). Similarly, AND
is fully encapsulated in the DHR cavity.
The DHR:anhydroretinol and
DHR:all-trans-4-oxoretinol complexes
The substrate-binding pocket accommodates the product an-
hydroretinol in basically the same orientation as retinol in
the DHR:PAP:RTL crystal structure (Fig. 5B). However,
the -ionone ring of anhydroretinol is rotated with respect
to that of the substrate. This conformational difference,
which requires no repositioning of the amino acids in the
lid, is in all probability a consequence of the fact that the
ring–isoprene chain dihedral angle is fixed by the C6–C7
double bond in the product, but not the substrate. Amino
acids Y120 and Y130 from the lid domain were identified to
be crucial for AR production. The -ionone ring in DHR:
PAP:AR is positioned closer to Y135 (4.8 Å versus 5.6 Å in
RTL complex), but farther away from Y112 (5.2 Å versus
3.6 Å), while its distance to Y120 (4.2 Å versus 3.9 Å) is
only slightly changed. The hydroxyl group of Y120 is fur-
ther removed from the putative proton abstraction site (6.9
Å versus 6.5 Å). These observations might suggest that
Y135 permits proton abstraction, while Y120 provides car-
bocation stabilization, although at this point, this is only
Figure 3. A secondary structure rendering of a monomer of the DHR:
PAP:RTL complex. Retinol and PAP molecules are shown as space-filled
renderings. The helical lid, which is the addition to the canonical sulfo-
trasferase fold, is represented by the top three helices. (Pictures 3–5 were
created using SETOR [Evans 1993].)
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speculation, since our structures do not provide details of
the transition state, and small distance differences may not
be significant. In any case, it appears that the binding site
can permit the transformation of retinol to anhydroretinol
with only modest protein conformational changes; only the
side chain of Y298 differs in its position in the active site.
In the DHR:PAP:OR complex, the orientation of the
-ionone ring with respect to amino acids Y112, Y120, and
Y135 of the lid approximates that in the enzyme:product
complex; however, the ring is flipped such that the 4-oxo
group is positioned where the dimethyl-substituted C1 of
the product is positioned in AR. The three dehydratase:reti-
noid structures (retinol, anhydroretinol, and 4-oxoretinol)
reveal three orientations for the retinoid ring-tail dihedral.
Figure 4. (A) Superposition of the androsterone binding site in DHR:
PAP:AND complex with estrogen molecule (shown in magenta) from
mouse estrogen sulfotransferase (EST). Electron density Fo-Fc simulated
annealed omit 2.35 Å resolution map for the omitted androsterone mol-
ecule contoured at 3.3. (B) Electron density Fo-Fc simulated annealed
omit 2.75 Å resolution map for the omitted anhydroretinol molecule in
DHR:PAP:AR complex contoured at 3.0. (C) Electron density Fo-Fc
simulated annealed omit 2.10 Å resolution map for the omitted all-trans-
4-oxoretinol molecule in DHR:PAP:OR complex contoured at 3.0.
Figure 5. The stereodiagram of the substrate binding site of DHR with
retinol molecule superimposed with corresponding parts of the (A) DHR:
PAP:AND, (B) DHR:PAP:AR, and (C) DHR:PAP:OR complexes. The lid
domain is shown as a ribbon diagram, superimposed substrate molecules as
well as corresponding protein side-chain residues which line the substrate
binding site are shown in magenta.
Retinol dehydratase
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As mentioned above, this angle is fixed by the C6–C7
double bond in AR, while in the 4-oxo derivative and reti-
nol, a range of dihedral angles is accessible. In the earlier
DHR:substrate structure, the ring-tail dihedral is 98°, close
to that observed in the high-resolution structure of RBP-
retinol (Calderone et al. 2003). However, the -ionone ring
of the substrate is flipped with respect to its orientation in
RBP. It appears that in the dehydratase binding site, the
ionone ring of the substrate is prepositioned for transforma-
tion to anhydroretinol. In contrast, the -ionone ring for the
inhibitor oxo-derivative is in accordance with the most com-
monly observed conformation. Transformation to product
from this position would require a 180° rotation about the
C6–C7 bond.
The different structures reveal alternate placement of the
isoprene tail of the retinoid as well; the position of the C9
methyl group is displaced 2.8 Å in both AR and OR com-
plexes in comparison to the RTL structure. Accompanying
changes in the protein structure are localized to the side
chain of Tyr 298, which rotates to permit the repositioning
of the C9 methyl group of the isoprene chain. Thus, one
might propose that during the course of catalysis, the con-
formational change in the retinoid necessitated by the con-
versions of the ring-tail single bond to a double bond is
compensated by movement of the isoprene tail and reposi-
tioning of Tyr 298. The ensemble of dehydratase structures
now available might suggest that it is the substrate that
provides the conformational flexibility to proceed through
the transition state.
Is retinol dehydratase the odd member
in the sulfotransferase family?
The superfamily of sulfotransferases currently comprises 47
mammalian isoforms, one insect isoform, and eight plant
isoforms (Blanchard et al. 2004). Although DHR is clearly
a member of the ST superfamily (as it utilizes the same
universal sulfate donor PAPS, is able to sulfonate many
hydroxycompounds, and has the typical sulfotransferase
fold), the biochemical activity of DHR appears to indicate
that it is a unique enzyme. A search against the GenBank
database with the DHR sequence reveals two proteins which
Figure 6. Sequence alignment between DHR, putative sulfotransferases AAF58309 (Drosophila melanogaster) and EAA01764
(Anopheles gambiae), and mouse estrogen sulfotransferase (EST), which was chosen as a classical representative of the sulfotransferase
superfamily. Triangles indicate amino acids which line the PAP-binding site, while stars indicate substrate binding-site residues in
DHR. The image was generated using the program ESPript (Gouet et al. 1999).
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appear to be like DHR, unconventional siblings in the su-
perfamily: a Drosophila melanogaster gene product (Gen-
Bank code AAF58309, 37% sequence identity with DHR),
and one from Anopheles gambiae (mosquito, GenBank code
EAA01764, 33% sequence identity). Both proteins have yet
unknown structure and function, but possess the DHR-like
lid domain insertion in a ST sequence (Fig. 6). The mod-
erate sequence identity and quite different amino acid com-
position of the lid domains in these proteins in comparison
to that of DHR may indicate that they are not necessarily
retinol dehydratases. But the presence of the similar lid
domain does suggest that these two proteins with yet un-
discovered catalytic activities could exploit a sulfonation
step as an intermediate, as in the case of DHR. An alterna-
tive interpretation may simply be that the insertion of the
helical cap in the insect enzymes further restricts the sub-
strate specificity of the sulfotransferases, or allows for a




The double mutant C258S:C279S of DHR was used for crystalli-
zation. It has the same activity as wild-type enzyme, but produces
crystals of better quality. Crystals of the ternary enzyme com-
plexes were obtained using the hanging-drop vapor-diffusion
method by mixing equal volumes of protein at 10 g/L (incu-
bated overnight with PAP, ethylmercurythiosalicilate, and anhy-
droretinol, androsterone or all-trans-4-oxoretinol solution in di-
methylsulfoxide) and the reservoir solution (8%–12% PEG3350,
100 mM sodium Hepes at pH 6.2–6.8, 8% glycerol) at 12°C.
Crystals usually appear in 2 wk.
Table 1. Data collection and refinement statistics
DHR:PAP:AND DHR:PAP:AR DHR:PAP:OR
Wavelength 1.5418 1.5418 1.5418
Resolution, (Å) 2.35 2.75 2.10
Space group P21 P21 P21
Cell dimensions
a (Å) 81.77 81.29 82.51
b (Å) 66.77 66.66 67.19
c (Å) 84.50 84.46 85.07
 (°) 111.17 110.66 111.85
No. of monomers per asymmetric unit 2 2 2
No. of unique reflections 32,003 19,441 45,373
Rsym
a,b (%) 8.7 (42.7) 11.3 (40.4) 9.3 (40.8)
Completeness (%) 94.5 (77.5) 95.5 (81.5) 89.0 (96.0)
Redundancies 3.4 (2.2) 3.6 (2.3) 2.7 (2.5)
I/ (I) 17.8 (1.9) 7.8 (1.9) 13.3 (2.4)
Refinement statistics
Resolution range 28.16–2.35 15–2.75 15–2.10
No. of reflections used in refinement 31,924 19,249 40,422
 cutoff used in refinement none none none
R/Rfree
c (%) 22.01/24.54 19.36/25.51 19.56/23.13
No. of refined atoms
Protein 5696 5698 5689
Heterogen atoms 98 102 102
Water 134 74 301
Average B-factors (Å2)
Protein 42.4 16.2 23.8
Substrate 41.6 57.1 57.8
R.m.s. deviations
Bonds (Å) 0.007 0.012 0.014
Angles (°) 1.30 1.53 1.59
Ramachandran statistics
Most favored regions (%) 93.3 90.7 91.9
Disallowed regions (%) 0.0 0.0 0.0
a Values in parentheses are for the highest-resolution shell.
b Rsym  ∑|Ii − 〈I〉|/∑Ii, where Ii is the intensity of the ith observation and 〈I〉 is the mean intensity of the
reflection.
c R  ∑||Fo| − |Fc||/∑|Fo|, where Fo and Fc are the observed and calculated structure factors amplitudes. Rfree
is calculated using 7.9%, 8.6% and 7.2% of reflections omitted from the refinement for the DHR:PAP:AND,
DHR:PAP:AR, and DHR:PAP:OR complexes, respectively.
Retinol dehydratase
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Data collection, structure solution, and refinement
Prior to data collections, crystals were coated with mineral oil and
flash frozen in a stream of liquid nitrogen at −170°C. X-ray data
were collected on a Raxis IV mounted on a Rigaku RU-200 ro-
tating anode. The images were processed and scaled using DENZO
and SCALEPACK (Otwinowski and Minor 1997). Data collection
and data processing statistics are summarized in Table 1.
Since crystals of all studied DHR complexes were isostructural
to the previously determined structure of DHR:PAP:RTL complex
(Pakhomova et al. 2001), we used rigid body refinement to posi-
tion the initial model (PDB accession code 1FLM; retinol and
water molecules were omitted from the model). The same Rfree
set from the DHR:PAP:RTL structure was used in every case
because of isomorphous character of all data sets. The positioned
models were refined using the maximum likelihood refinement in
REFMAC (CCP4 1994) (DHR:PAP:AR, DHR:PAP:OR com-
plexes) or CNS (Brünger et all. 1998) (DHR:PAP:AND complex).
No  cutoff was applied to the data. Twofold noncrystallographic
symmetry restraints, as well as bulk solvent corrections, were ap-
plied in every case. The program O (Jones et al. 1991) was used to
build the models throughout the refinement. Refinement statistics
are listed in Table 1. Details of refinement of each of the structures
follow.
DHR:PAP:AND
The final model consists of residues 7–349 for both protein mono-
mers, two cofactor PAP, two androsterone molecules, two Ca+2
ions, and 134 water molecules. H239 (monomer A) was modeled
in two alternate conformations. Two cis peptide bonds (residue
P226 in both molecules) were detected.
DHR:PAP:AR
The final structure includes residues 6–349 for both protein mol-
ecules, two cofactor PAP, two anhydroretinol molecules, two Ca+2
ions, and 74 water molecules. Additional electron density on cys-
teines 318 (both molecules) was interpreted as from covalently
bound ethylmercury residues. Two cis peptide bonds (residue P226
in both molecules) were detected.
DHR:PAP:OR
The final model consists of residues 8–349 for both protein mono-
mers, two cofactor PAP, two all-trans-4-oxoretinol molecules, two
Ca+2 ions, two Hg+2 ions (bound to C318), and 301 water mol-
ecules. Two cis peptide bonds (residue P226 in both molecules)
were detected, similarly as in previous complexes.
Data deposition
The atomic coordinates have been deposited to the Protein Data
Bank with the accession codes: DHR:PAP:AND, 1X8J; DHR:
PAP:AR, 1X8K; DHR:PAP:OR, 1X8L.
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